Clinical Trials
Greater Occipital Nerve Block for Migraine Prophylaxis
Location:
Trial status:
ClosedWhy is this study being done?
The purpose of this study is to determine whether greater occipital nerve block injection reduces the frequency of migraine headaches.
Who is eligible to participate?
Inclusion Criteria:
- Age 18-75 years.
- ICHD-II episodic or chronic migraine.
- At least 1 attack per week.
Exclusion Criteria:
- Pregnant or lactating.
- Continuous headache.
- Maintenance opioid medication.
- Started migraine prophylactic medication within the past 2 months.
- Hypersensitivity to study ingredients.
- Investigational medication within 90 days of screening.
- Injection site infection at injection visit.
- Systemic infection at injection visit.
- Cranial bone defect.
- Chronic cluster headache, new daily persistent headache, hemicrania continua, or chronic tension type headache.
Last updated: 03/05/2013
NCT ID:
NCT00915473- Legal restrictions and terms of use applicable to this site
- Use of this site signifies your agreement to the terms of use.
- © 1998-2012 Mayo Foundation for Medical Education and Research. All rights reserved.